Antengene Corporation Limited ("Antengene", SEHK: 6996.HK) is a biopharmaceutical company with an integrated drug discovery clinical development approach, anchored in Asia Pacific with a global footprint. Antengene aims to provide the most advanced anti-cancer drugs to patients in China, the Asia Pacific Region around the world. Since its official start in April 2017, Antengene has built a pipeline of 12 clinical pre-clinical stage assets, obtained 9 IND approvals has 9 ongoing cross-regional clinical trials in Asia Pacific. At Antengene, we focus on developing drug candidates with novel MoAs first-in-/best-in- potential to address significant unmet medical needs. The vision of Antengene is to "Treat Patients Beyond Borders" through research, development commercialization of first-in-/best-in- therapeutics.
Provided by
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows
Jobui does not provide an APP. Please follow our WeChat official account.
